Search Results 1751-1760 of 16779 for Bioavailability
The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.
ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest oncology findings at the 2025 American Society of Clinical ...
Hearing loss often is thought of as a normal part of aging, but recent studies have shown untreated hearing loss can significantly affect overall health.[.
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Marla Broadfoot, Ph.D. September 17, 2024. More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth; Preoperative radiotherapy survival.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
A Mayo discovery could lead to future strategies for detecting the disease in its earliest, precancerous stages. Latest stories.
About this study. This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib ...
Health & Wellness ; Cancer Diagnosis: 11 Tips for Coping. Jennifer O'Hara. April 24, 2015 ; MAYO CLINIC RADIO. Dana Sparks. April 23, 2015 ; Heart Surgery Puts ISU ...
At Mayo Clinic, biomedical engineer Benjamin Brinkmann, Ph.D., is developing tools and technologies that help reveal brain patterns — making epileptic seizures ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.